Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FNCB 'moderately effective' at retrieving clinically-useful GI samples
The team reviewed GI samples from 25 dogs and 19 cats obtained by fine needle cytology biopsies.
Study published in the JSAP reviewed GI samples from 25 dogs and 19 cats.

Ultrasound-guided fine needle cytology biopsies (FNCB) are moderately effective at retrieving clinically-useful samples from gastrointestinal lesions (GI lesions), according to new research.

Published in the Journal of Small Animal Practice, the study aimed to assess factors that may influence the clinical usefulness of samples collected from GI lesions by FNCB. The team reviewed GI samples from 25 dogs and 19 cats obtained by FNCB from a single institution between February 2014 to August 2016.

Researchers evaluated the clinical records to obtain historical data, clinical findings, diagnostic results and patient outcomes. Lesion thickness was categorised further as either a mass (≥20 mm thickness) or a thickening (<20mm).

The team also reviewed factors that may have influenced the retrieval of a clinically useful sample. These included the lesion location, sonographic lesion thickness, the loss of (or alteration to) the intestinal layer conspicuity on ultrasound, and the number of slides submitted to the cytologists.

Study author Dr Robert Turner, a registrar in veterinary radiology at the University of Melbourne, said: “Of the submitted cytological samples, 68 per cent (30/44) were considered clinically useful, including 11 of 18 from the stomach, eight of 12 from the small intestine, five of six from the ileocaecal junction and six of eight cases from the colon.

"The study found that both increasing lesion thickness and the number of slides submitted to the cytologists were positively associated with the odds of obtaining a clinically useful sample. In a multivariable logistic regression model, some evidence was obtained that these factors were related, but the available data was insufficient to precisely estimate their combined effect.”

JSAP editor, Nicola Di Girolamo, concluded: “The results of this study indicate that ultrasound-guided percutaneous cytology is moderately effective at retrieving clinically useful samples from GI lesions. Future research including larger, prospective studies would help to ascertain safety of this diagnostic technique, potential inter-operator variability, as well as a pragmatic comparison in terms of patient outcomes with the current standards for diagnosing GI lesions.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.